The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
Open accessAbstract
Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell-T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memory-induced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to enhance T cell-based immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
Self-citationJoshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
The CD28 Signaling Pathway Regulates Glucose Metabolism
Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., & Thompson, C. B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00323-0 · Cited by 1,475
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952
Self-citationRathmell, J. C., Fox, C. J., Plas, D. R., Hammerman, P. S., Cinalli, R. M., & Thompson, C. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7315-7328.2003 · Cited by 572
Mackall, C. L., Fleisher, T. A., Brown, M. R., Andrich, M. P., Chen, C. C., Feuerstein, I. M., Magrath, I. T., Wexler, L. H., Dimitrov, D. S., & Gress, R. E. (1997) · Blood · doi:10.1182/blood.v89.10.3700 · Cited by 400
Graef, P., Buchholz, V. R., Stemberger, C., Flossdorf, M., Henkel, L., Schiemann, M., Drexler, I., Höfer, T., Riddell, S. R., & Busch, D. H. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.018 · Cited by 311
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309
Subcellular localization of hexokinases I and II directs the metabolic fate of glucose
John, S., Weiss, J. N., & Ribalet, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017674 · Cited by 239
Rufer, N., Zippelius, A., Batard, P., Pittet, M. J., Kurth, I., Corthesy, P., Cerottini, J.-C., Leyvraz, S., Roosnek, E., Nabholz, M., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0420 · Cited by 182
Corsini, N. S., Sancho-Martinez, I., Laudenklos, S., Glagow, D., Kumar, S., Letellier, E., Koch, P., Teodorczyk, M., Kleber, S., Klussmann, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.004 · Cited by 129
Casati, A., Varghaei-Nahvi, A., Feldman, S. A., Assenmacher, M., Rosenberg, S. A., Dudley, M. E., & Scheffold, A. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1459-x · Cited by 73
Self-citation
Research works printed but not linked: 64
- 10.1146/annurev-immunol-032713-120136 · DOI · Paper page
- 10.1111/imr.12139 · DOI
- 10.1126/science.aaa4967 · DOI · Paper page
- 10.1097/PPO.0b013e3181c51f37 · DOI
- 10.1111/imr.12138 · DOI
- 10.1038/nrclinonc.2012.111 · DOI · Paper page
- 10.1182/blood-2010-01-043737 · DOI · Paper page
- 10.1038/nrc3565 · DOI · Paper page
- 10.1038/nri2635 · DOI · Paper page
- 10.1111/imr.12131 · DOI · Paper page
- 10.1073/pnas.0907448106 · DOI · Paper page
- 10.1182/blood-2012-05-431718 · DOI · Paper page
- 10.1182/blood-2010-05-286286 · DOI · Paper page
- 10.1182/blood-2014-01-552174 · DOI · Paper page
- 10.1158/1078-0432.CCR-11-0116 · DOI · Paper page
- 10.1182/blood-2011-05-354449 · DOI · Paper page
- 10.1038/jid.2011.160 · DOI
- 10.1097/CJI.0b013e31827806e6 · DOI · Paper page
- 10.1016/j.immuni.2008.05.017 · DOI
- 10.1038/ni.2547 · DOI
- 10.1084/jem.20030590 · DOI · Paper page
- Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia, Sci Transl Med, 3, 10.1126/scitranslmed.3002842 · DOI · Paper page
- 10.1038/nm.1982 · DOI · Paper page
- Gattinoni, 2012, Paths to stemness: building the ultimate antitumour T cell, Cancer, 12, 671
- Schober, 1999, Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo, J Immunol, 163, 3662, 10.4049/jimmunol.163.7.3662 · DOI
- 10.1016/j.immuni.2012.01.015 · DOI · Paper page
- 10.1016/j.immuni.2009.05.014 · DOI · Paper page
- 10.4049/jimmunol.1100698 · doi:10.4049/jimmunol.1100698
- 10.1084/jem.192.8.1105 · DOI · Paper page
- 10.1038/nri2526 · DOI · Paper page
- 10.1016/j.immuni.2014.11.001 · DOI · Paper page
- 10.1016/j.cell.2007.04.031 · DOI · Paper page
- 10.1084/jem.178.6.2231 · DOI · Paper page
- 10.1038/78688 · DOI · Paper page
- 10.1038/356314a0 · DOI · Paper page
- 10.1038/cdd.2010.155 · DOI
- 10.1038/sj.emboj.7601456 · DOI · Paper page
- 10.1038/sj.emboj.7601460 · DOI · Paper page
- 10.1016/j.immuni.2011.01.012 · DOI · Paper page
- 10.1038/ni.1689 · DOI · Paper page
- 10.4049/jimmunol.181.5.2980 · DOI · Paper page
- 10.1038/sj.emboj.7601761 · DOI
- 10.1158/0008-5472.CAN-14-2277 · DOI · Paper page
- 10.1016/j.bbmt.2010.03.014 · DOI · Paper page
- 10.1200/JCO.2010.32.2537 · DOI · Paper page
- 10.1200/JCO.2014.56.2025 · DOI · Paper page
- 10.1073/pnas.0503726102 · DOI · Paper page
- 10.1182/blood-2010-10-310599 · DOI · Paper page
- 10.1172/JCI32103 · DOI · Paper page
- 10.1371/journal.pone.0035798 · DOI
- 10.1182/blood-2011-07-366419 · DOI · Paper page
- 10.4049/jimmunol.177.3.1481 · DOI
- 10.1016/j.cell.2012.08.015 · DOI · Paper page
- 10.1016/j.immuni.2009.06.023 · DOI
- 10.1038/ni1469 · DOI · Paper page
- 10.4049/jimmunol.1101579 · DOI
- Rutherford, 2012, Bacterial quorum sensing: its role in virulence and possibilities for its control, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a012427 · DOI · Paper page
- 10.1073/pnas.1222467110 · DOI
- 10.1016/j.jtbi.2013.12.019 · doi:10.1016/j.jtbi.2013.12.019
- 10.1073/pnas.1209115109 · DOI
- 10.1084/jem.20122759 · DOI
- 10.1016/0092-8674(94)90169-4 · DOI · Paper page
- Klebanoff, 2011, Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice, Cancer Res, 17, 5343
- 10.1172/JCI24480 · DOI · Paper page
Cited by
T memory stem cells in health and disease
Gattinoni, L., Speiser, D. E., Lichterfeld, M., & Bonini, C. (2017) · Nature Medicine · doi:10.1038/nm.4241 · Cited by 620
Self-citationAn introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
Feins, S., Kong, W., Williams, E. F., Milone, M. C., & Fraietta, J. A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25418 · Cited by 614
Regulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
Epigenetic control of CD8+ T cell differentiation
Henning, A. N., Roychoudhuri, R., & Restifo, N. P. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.146 · Cited by 510
Self-citationHurton, L. V., Singh, H., Najjar, A. M., Switzer, K. C., Mi, T., Maiti, S., Olivares, S., Rabinovich, B., Huls, H., Forget, M.-A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610544113 · Cited by 461
Metadata
- Authors
- Klebanoff, C. A., Scott, C. D., Leonardi, A. J., Yamamoto, T. N., Cruz, A. C., Ouyang, C., Ramaswamy, M., Roychoudhuri, R., Ji, Y., Eil, R. L., Sukumar, M., Crompton, J. G., Palmer, D. C., Borman, Z. A., Clever, D., Thomas, S. K., Patel, S., Yu, Z., Muranski, P., Liu, H., Wang, E., Marincola, F. M., Gros, A., Gattinoni, L., Rosenberg, S. A., Siegel, R. M., & Restifo, N. P.
- Venue
- Journal of Clinical Investigation
- Published
- 2015-12-14
- Volume
- 126
- Issue
- 1
- Pages
- 318-334
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2211359813
- Cited by
- 243
- References
- 14
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.